Pharmacokinetics, Bioequivalence, and Safety Study of Trimedat® 76,95 mg Orally Disintegrating Tablets and Trimedat® 100 mg Tablets in Healthy Volunteers.

Clinical trial NCT07421011 · RECRUITING

Trial details

NCT number: NCT07421011
Sponsor: Valenta Pharm JSC
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Irritable Bowel Syndrome Gallstone Disease GERD Biliary Dyskinesia Postcholecystectomy Syndrome

Start date: 2025-11-06
Primary completion: 2026-12-31
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.